These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 16080677

  • 1. FDA dependence on drug industry.
    Lawson GW.
    J Natl Med Assoc; 2005 Jul; 97(7):1039-40. PubMed ID: 16080677
    [No Abstract] [Full Text] [Related]

  • 2. User fees and beyond--the FDA Safety and Innovation Act of 2012.
    Kramer DB, Kesselheim AS.
    N Engl J Med; 2012 Oct 04; 367(14):1277-9. PubMed ID: 23034017
    [No Abstract] [Full Text] [Related]

  • 3. Paying for drug approvals--who's using whom?
    Avorn J.
    N Engl J Med; 2007 Apr 26; 356(17):1697-700. PubMed ID: 17435083
    [No Abstract] [Full Text] [Related]

  • 4. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M.
    N Engl J Med; 2007 Apr 26; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract] [Full Text] [Related]

  • 5. PDUFA reauthorization--drug safety's golden moment of opportunity?
    Hennessy S, Strom BL.
    N Engl J Med; 2007 Apr 26; 356(17):1703-4. PubMed ID: 17435082
    [No Abstract] [Full Text] [Related]

  • 6. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL.
    Food Drug Law J; 2005 Apr 26; 60(2):261-338. PubMed ID: 16094773
    [No Abstract] [Full Text] [Related]

  • 7. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
    Bierut MB.
    Healthspan; 1992 Dec 26; 9(11):12-4. PubMed ID: 10123552
    [No Abstract] [Full Text] [Related]

  • 8. FDA joins market.
    Gershon D.
    Nature; 1993 Jul 08; 364(6433):93. PubMed ID: 8321293
    [No Abstract] [Full Text] [Related]

  • 9. What ails the FDA?
    Okie S.
    N Engl J Med; 2005 Mar 17; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. User fees to hasten FDA review.
    Gershon D.
    Nature; 1992 Oct 15; 359(6396):567. PubMed ID: 1406982
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulatory watch: impact of PDUFA on regulatory decision-making.
    Hay M.
    Nat Rev Drug Discov; 2010 Aug 15; 9(8):585. PubMed ID: 20671755
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Food and Drug Administration.
    Horton LR.
    BMJ; 2007 Jan 13; 334(7584):55-6. PubMed ID: 17218671
    [Abstract] [Full Text] [Related]

  • 16. User fees for faster drug reviews. Are they helping or hurting the public health?
    Thompson L.
    FDA Consum; 2000 Jan 13; 34(5):25-9. PubMed ID: 11590789
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FDA user fees and innovation.
    Somberg J.
    Am J Ther; 2008 Jan 13; 15(2):97. PubMed ID: 18356626
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.